SBK治疗近视临床观察

Clinical observation of SBK for treatment of myopia

目的:探讨准分子激光前弹力层下角膜磨镶术(subBowman's keratomileusis,SBK)治疗近视的临床疗效。方法:回顾2009-12/2010-06间采用SBK治疗近视患者71例142眼的术前及术后6mo的视力、屈光度和角膜前后表面高度的变化。结果:术后6mo患者裸眼视力0.8~1.5,平均1.14±0.17,所有患者UCVA均≥0.8,UCVA≥1.0者136眼(95.8%),UCVA≥1.2者64眼(45.1%);术后6mo最佳矫正视力(BCVA)除2例3眼较前下降1行外,其余与术前相同或提高,BCVA均≥0.8,BCVA均≥1.0者136眼(95.8%),BCVA≥1.2者70眼(49.3%),术后6mo64眼(45.1%)UCVA≥术前BCVA。屈光度:术后6mo等效球镜(SE)为-0.65^+0.97(平均0.15±0.41)D。SE均≤±1.00D,92.8%≤±0.5D。术后6mo观察角膜前后表面高度变化大致相同。结论:SBK治疗近视有良好的预测性、准确性及安全性。

AIM：To investigate the clinical efficacy of sub-Bowman’s keratomileusis（SBK）for treatment of myopia.METHODS：From December 2009 to June 2010,71 patients 142 eyes underwent the treatment of myopia by SBK.Their visual acuity,refraction,anterior and posterior corneal surface height changes before and 6 months after operation were reviewed.RESULTS：The uncorrected visual acuity（UCVA）of patients 6 months after operation were 0.8-1.5,average 1.14±0.17,UCVA of all patients were≥0.8,UCVA were≥1.0 in 136 eyes,accounting for 95.8%,UCVA were≥1.2 in 64 eyes,accounting for 45.1%;Except for 3 eyes of 2 cases with 1 line down,the best-corrected visual acuity（BCVA）of the others 6 months after operation were the same with or better than preoperative,all BCVA were≥0.8,BCVA were≥1.0 in 136 eyes（95.8%）BCVA≥1.2 in 70 eyes（49.3%）,64 eyes（45.1%）with UCVA≥preoperative BCVA 6 months after operation.Diopter：spherical equivalent（SE）were（-0.65-＋0.97）D,average（0.15±0.41）D.All SE were ≤±1.0D,92.8%≤±0.5D 6 months after operation.Anterior and posterior corneal surface height changes were roughly the same 6 months after operation.CONCLUSION：SBK treatment of myopia has good predictability,accuracy and safety.